Your browser doesn't support javascript.
loading
Reduced Brain Cannabinoid Receptor Availability in Schizophrenia.
Ranganathan, Mohini; Cortes-Briones, Jose; Radhakrishnan, Rajiv; Thurnauer, Halle; Planeta, Beata; Skosnik, Patrick; Gao, Hong; Labaree, David; Neumeister, Alexander; Pittman, Brian; Surti, Toral; Huang, Yiyun; Carson, Richard E; D'Souza, Deepak Cyril.
Afiliação
  • Ranganathan M; Schizophrenia and Neuropharmacology Research Group, Veterans Affairs Connecticut Healthcare System, West Haven; Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut. Electronic address:
  • Cortes-Briones J; Schizophrenia and Neuropharmacology Research Group, Veterans Affairs Connecticut Healthcare System, West Haven; Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut.
  • Radhakrishnan R; Schizophrenia and Neuropharmacology Research Group, Veterans Affairs Connecticut Healthcare System, West Haven; Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut.
  • Thurnauer H; Schizophrenia and Neuropharmacology Research Group, Veterans Affairs Connecticut Healthcare System, West Haven; Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut.
  • Planeta B; Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut; Positron Emission Tomography Center, Yale University School of Medicine, New Haven, Connecticut.
  • Skosnik P; Schizophrenia and Neuropharmacology Research Group, Veterans Affairs Connecticut Healthcare System, West Haven; Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut.
  • Gao H; Positron Emission Tomography Center, Yale University School of Medicine, New Haven, Connecticut.
  • Labaree D; Positron Emission Tomography Center, Yale University School of Medicine, New Haven, Connecticut.
  • Neumeister A; Molecular Imaging Program for Mood and Anxiety Disorders, New York University Langone Medical Center, New York, New York.
  • Pittman B; Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut; Positron Emission Tomography Center, Yale University School of Medicine, New Haven, Connecticut.
  • Surti T; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut.
  • Huang Y; Positron Emission Tomography Center, Yale University School of Medicine, New Haven, Connecticut.
  • Carson RE; Positron Emission Tomography Center, Yale University School of Medicine, New Haven, Connecticut.
  • D'Souza DC; Schizophrenia and Neuropharmacology Research Group, Veterans Affairs Connecticut Healthcare System, West Haven; Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven; Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut.
Biol Psychiatry ; 79(12): 997-1005, 2016 06 15.
Article em En | MEDLINE | ID: mdl-26432420
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Receptor CB1 de Canabinoide / Tomografia por Emissão de Pósitrons Tipo de estudo: Prognostic_studies Limite: Adult / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Receptor CB1 de Canabinoide / Tomografia por Emissão de Pósitrons Tipo de estudo: Prognostic_studies Limite: Adult / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article